Molecular Characterization and Immuno-Reactivity Patterns of a Novel Plasmodium falciparum Armadillo-Type Repeat

Emmanuel Amlabu1,2, Philip Ilani1, Grace Opoku1

  • 1West African Center for Cell Biology of Infectious Pathogens, University of Ghana, Accra, Ghana.

Insights

Researchers identified a new protein, Plasmodium falciparum Armadillo-Type Repeat Protein (PfATRP), in malaria parasites. PfATRP is present in merozoites and elicits a natural antibody response in infected children.

Area of Science:

  • Malariology
  • Molecular Parasitology
  • Structural Biology

Background:

  • Many Plasmodium falciparum genes lack functional characterization.
  • Understanding novel parasite proteins is crucial for malaria control.

Purpose of the Study:

  • To functionally characterize the uncharacterized gene PF3D7_0410600.
  • To investigate the role of the Plasmodium falciparum Armadillo-Type Repeat Protein (PfATRP) in parasite biology.

Main Methods:

  • Homology-based structural modeling to identify Armadillo repeats.
  • Bacterial expression and purification of recombinant PfATRP.
  • Mass spectrometry and antibody generation for protein validation.
  • Immunofluorescence assays to determine protein localization.
  • Schizont arrest assays to assess egress phenotype.
  • Dual immunofluorescence to analyze co-localization with cellular markers.
  • Screening of plasma samples for naturally acquired antibodies.

Main Results:

  • Identified and characterized a novel protein, PfATRP, containing Armadillo repeats.
  • Confirmed PfATRP expression in intraerythrocytic stages, with localization in merozoites.
  • PfATRP is not accessible on the surface of intact merozoites.
  • PfATRP partially co-localizes with the inner membrane complex and microtubules.
  • Malaria-infected children possess naturally acquired antibodies against PfATRP.

Conclusions:

  • PfATRP is a novel Plasmodium falciparum protein with potential roles in parasite development.
  • The presence of PfATRP-specific antibodies in infected individuals suggests its potential as a biomarker or vaccine target.